Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. PARKS ME
    Stochastic model of Alzheimer's disease progression using two-state Markov chains.
    PLoS One. 2024;19:e0295578.
    >> Share

  2. KONG F, Wu T, Dai J, Cai J, et al
    Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.
    PLoS One. 2024;19:e0295008.
    >> Share

  3. GAMMIE SC, Messing A, Hill MA, Kelm-Nelson CA, et al
    Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
    PLoS One. 2024;19:e0291995.
    >> Share


  4. Editorial Note: Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease.
    PLoS One. 2024;19:e0297928.
    >> Share

  5. NEUDORF B, Dinh C, Barnes V, Stergiou-Dayment C, et al
    Enhancing Minds in Motion(R) as a virtual program delivery model for people living with dementia and their care partners.
    PLoS One. 2024;19:e0291166.
    >> Share

  6. PAPAZOGLOU A, Henseler C, Weickhardt S, Teipelke J, et al
    Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice.
    PLoS One. 2024;19:e0296959.
    >> Share

  7. BELLIO TA, Laguna-Torres JY, Campion MS, Chou J, et al
    Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Abeta42 deposition in AppNL-G-F Alzheimer's disease model mice.
    PLoS One. 2024;19:e0297289.
    >> Share

  8. SINGH S, Cocoros NM, Li X, Mazor KM, et al
    Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controll
    PLoS One. 2024;19:e0297562.
    >> Share

  9. KO YK, Kim E, Lee EJ, Nam SJ, et al
    Enrichment of infection-associated bacteria in the low biomass brain bacteriota of Alzheimer's disease patients.
    PLoS One. 2024;19:e0296307.
    >> Share

  10. LI YS, Xia YG, Liu YL, Jiang WR, et al
    Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297883.
    >> Share

  11. SHAHID SS, Dzemidzic M, Butch ER, Jarvis EE, et al
    Estimating the synaptic density deficit in Alzheimer's disease using multi-contrast CEST imaging.
    PLoS One. 2024;19:e0299961.
    >> Share

  12. ABAYOMI SN, Sritharan P, Yan E, Saripella A, et al
    The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298686.
    >> Share

  13. AHMADI M, Javaheri D, Khajavi M, Danesh K, et al
    A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction.
    PLoS One. 2024;19:e0297996.
    >> Share

  14. ROYALL DR, Palmer RF
    INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.
    PLoS One. 2024;19:e0295386.
    >> Share

  15. YU F, Pituch KA, Maxfield M, Baena E, et al
    The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    PLoS One. 2024;19:e0295749.
    >> Share

  16. PEREIRA AAR, Pinto AM, Malerba HN, Toricelli M, et al
    Microdose lithium improves behavioral deficits and modulates molecular mechanisms of memory formation in female SAMP-8, a mouse model of accelerated aging.
    PLoS One. 2024;19:e0299534.
    >> Share

    January 2023
  17. COUGHLAN G, Plumb W, Zhukovsky P, Aung MH, et al
    Vestibular contribution to path integration deficits in 'at-genetic-risk' for Alzheimer's disease.
    PLoS One. 2023;18:e0278239.
    >> Share

  18. CHANG HT, Chiu PY
    Development of a simple screening tool for determining cognitive status in Alzheimer's disease.
    PLoS One. 2023;18:e0280178.
    >> Share

  19. DEBNATH S, Sharma D, Chaudhari SY, Sharma R, et al
    Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
    PLoS One. 2023;18:e0279616.
    >> Share

  20. SHAFIGHI K, Villeneuve S, Rosa Neto P, Badhwar A, et al
    Social isolation is linked to classical risk factors of Alzheimer's disease-related dementias.
    PLoS One. 2023;18:e0280471.
    >> Share

  21. CHATTERJEE S, Sealey M, Ruiz E, Pegasiou CM, et al
    Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration.
    PLoS One. 2023;18:e0262792.
    >> Share

  22. ZHENG X, Cawood J, Hayre C, Wang S, et al
    Computer assisted diagnosis of Alzheimer's disease using statistical likelihood-ratio test.
    PLoS One. 2023;18:e0279574.
    >> Share

  23. JETT S, Dyke JP, Boneu Yepez C, Zarate C, et al
    Effects of sex and APOE epsilon4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.
    PLoS One. 2023;18:e0281302.
    >> Share

  24. LANDES SD, Finan JM, Turk MA
    Reporting Down syndrome on the death certificate for Alzheimer disease/unspecified dementia deaths.
    PLoS One. 2023;18:e0281763.
    >> Share

  25. SOREQ L, Bird H, Mohamed W, Hardy J, et al
    Single-cell RNA sequencing analysis of human Alzheimer's disease brain samples reveals neuronal and glial specific cells differential expression.
    PLoS One. 2023;18:e0277630.
    >> Share

  26. TIAN Y, Kuruvilla MV, Park M
    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol.
    PLoS One. 2023;18:e0282436.
    >> Share

  27. GARCIA MANRIQUEZ BA, Papapanagiotou JA, Strysick CA, Green EH, et al
    Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    PLoS One. 2023;18:e0275137.
    >> Share

  28. KARAMACOSKA D, Chan DKY, Leung I, Liu JX, et al
    Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
    PLoS One. 2023;18:e0265285.
    >> Share

  29. SHOBEIRI P, Alilou S, Jaberinezhad M, Zare F, et al
    Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281784.
    >> Share

  30. LI Y, Liu H, Li R
    Study of Bayesian variable selection method on mixed linear regression models.
    PLoS One. 2023;18:e0283100.
    >> Share

  31. LEE LH, Wu SC, Ho CF, Liang WL, et al
    White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
    PLoS One. 2023;18:e0283790.
    >> Share

  32. MRAZ H, Tong CY, Liu KPY
    Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial.
    PLoS One. 2023;18:e0283449.
    >> Share

  33. AMORIM IS, Challal S, Cistarelli L, Dorval T, et al
    A seeding-based neuronal model of tau aggregation for use in drug discovery.
    PLoS One. 2023;18:e0283941.
    >> Share

  34. FAISAL M, Aid J, Nodirov B, Lee B, et al
    Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.
    PLoS One. 2023;18:e0281003.
    >> Share

  35. BAKER E, Leonenko G, Schmidt KM, Hill M, et al
    What does heritability of Alzheimer's disease represent?
    PLoS One. 2023;18:e0281440.
    >> Share

  36. GIRGIN M, Isik S, Kantarci-Carsibasi N
    Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2023;18:e0284994.
    >> Share

  37. BAUZA M, Krstulovic M, Krupic J
    Unsupervised, frequent and remote: A novel platform for personalised digital phenotyping of long-term memory in humans.
    PLoS One. 2023;18:e0284220.
    >> Share

  38. ALATRANY AS, Khan W, Hussain A, Al-Jumeily D, et al
    Wide and deep learning based approaches for classification of Alzheimer's disease using genome-wide association studies.
    PLoS One. 2023;18:e0283712.
    >> Share

  39. SHEPHERD-BANIGAN M, Miller KEM, Hastings SN, Schleiden LJ, et al
    Use of high cost care among Veterans with comorbid mental illness and Alzheimer's Disease and related dementias.
    PLoS One. 2023;18:e0282071.
    >> Share

  40. MURPHY C, Dyer AH, Lawlor B, Kennelly SP, et al
    What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
    PLoS One. 2023;18:e0285529.
    >> Share

  41. GATTO RG, Carlos AF, Reichard RR, Lowe VJ, et al
    Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
    PLoS One. 2023;18:e0284182.
    >> Share

  42. FARINA MP, Saenz J, Crimmins EM
    Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?
    PLoS One. 2023;18:e0285220.
    >> Share

  43. TAULE T, Eide IS, Fjaer L, Myrberget MA, et al
    Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
    PLoS One. 2023;18:e0285307.
    >> Share

  44. JEMIMAH S, Chabib CMM, Hadjileontiadis L, AlShehhi A, et al
    Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0285346.
    >> Share

  45. SU Y, Wang D, Liu N, Yang J, et al
    Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis.
    PLoS One. 2023;18:e0286086.
    >> Share

  46. BRAUN DJ, Frazier HN, Davis VA, Coleman MJ, et al
    Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    PLoS One. 2023;18:e0286495.
    >> Share

  47. RADWAN AA, Alanazi FK, Raish M
    Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-beta aggregation: Molecular modeling and in vitro evaluation.
    PLoS One. 2023;18:e0286195.
    >> Share

  48. JEONG WC, Min JY, Kang TG, Bae H, et al
    Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy.
    PLoS One. 2023;18:e0286727.
    >> Share

  49. TSIANOU CC, Kvetina J, Radochova V, Kohoutova D, et al
    The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2023;18:e0286386.
    >> Share

  50. HANTKE NC, Kaye J, Mattek N, Wu CY, et al
    Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology.
    PLoS One. 2023;18:e0286812.
    >> Share

  51. WU S, Stogios N, Hahn M, Navagnanavel J, et al
    Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286887.
    >> Share

  52. MUURLING M, Pasmooij AMG, Koychev I, Roik D, et al
    Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
    PLoS One. 2023;18:e0285807.
    >> Share

  53. KHAYER N, Motamed N, Marashi SA, Goshadrou F, et al
    RT-DOb, a switch gene for the gene pair Csf1r, Milr1, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.
    PLoS One. 2023;18:e0288134.
    >> Share

  54. MEKLI K, Lophatananon A, Maharani A, Nazroo JY, et al
    Association between an inflammatory biomarker score and future dementia diagnosis in the population-based UK Biobank cohort of 500,000 people.
    PLoS One. 2023;18:e0288045.
    >> Share

  55. THAMMASART S, Namchaiw P, Pasuwat K, Tonsomboon K, et al
    Attenuation Abeta1-42-induced neurotoxicity in neuronal cell by 660nm and 810nm LED light irradiation.
    PLoS One. 2023;18:e0283976.
    >> Share

  56. WILLIAMS E, Theys C, McAuliffe M
    Lexical-semantic properties of verbs and nouns used in conversation by people with Alzheimer's disease.
    PLoS One. 2023;18:e0288556.
    >> Share

  57. SUN Z, Zhang Y, Zhang M, Zhou S, et al
    Integrated brain and plasma dual-channel metabolomics to explore the treatment effects of Alpinia oxyphyllaFructus on Alzheimer's disease.
    PLoS One. 2023;18:e0285401.
    >> Share

  58. NI P, Pan K, Zhao B
    Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    PLoS One. 2023;18:e0289068.
    >> Share

  59. LU H, Li J, Yang NS, Lam LCW, et al
    Using gamma-band transcranial alternating current stimulation (tACS) to improve sleep quality and cognition in patients with mild neurocognitive disorders due to Alzheimer's disease: A study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0289591.
    >> Share

  60. MONIN JK, McAvay G, Zang E, Vander Wyk B, et al
    Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study.
    PLoS One. 2023;18:e0289311.
    >> Share

  61. YOON JA, Kong IJ, Choi I, Cha J, et al
    Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer's disease: An exploratory study.
    PLoS One. 2023;18:e0285013.
    >> Share

  62. BASTOS M, da Silva MP, da Silva D, Negrao GN, et al
    Factors associated with Alzheimer's disease prevalence and mortality in Brazil-An ecological study.
    PLoS One. 2023;18:e0283936.
    >> Share

  63. ROVANG MS, Selnes P, MacIntosh BJ, Rasmus Groote I, et al
    Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
    PLoS One. 2023;18:e0285683.
    >> Share

  64. YAGHMAEI E, Pierce A, Lu H, Patel YM, et al
    A causal inference study: The impact of the combined administration of Donepezil and Memantine on decreasing hospital and emergency department visits of Alzheimer's disease patients.
    PLoS One. 2023;18:e0291362.
    >> Share

  65. STOLZENBURG LR, Esmaeeli S, Kulkarni AS, Murphy E, et al
    Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model.
    PLoS One. 2023;18:e0291029.
    >> Share

  66. NGUYEN TTT, Lee HH, Huang LK, Hu CJ, et al
    Heterogeneity of Alzheimer's disease identified by neuropsychological test profiling.
    PLoS One. 2023;18:e0292527.
    >> Share

  67. ZHANG GH, Chin KL, Yan SY, Pare R, et al
    Antioxioxidant and antiapoptotic effects of Thymosin beta4 in Abeta-induced SH-SY5Y cells via the 5-HTR1A/ERK axis.
    PLoS One. 2023;18:e0287817.
    >> Share

  68. HENRY DS, Pellegrino RG
    A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
    PLoS One. 2023;18:e0292863.
    >> Share

  69. ZHOU Q, Yang D, Xiong C, Li X, et al
    Atopic dermatitis and cognitive dysfunction in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0292987.
    >> Share

  70. BOYANOVA ST, Lloyd-Morris E, Corpe C, Rahman KM, et al
    Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
    PLoS One. 2023;18:e0286278.
    >> Share

  71. KOYCHEV I, Marinov E, Young S, Lazarova S, et al
    Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
    PLoS One. 2023;18:e0288039.
    >> Share

  72. ISMAIL H, Khalid D, Waseem D, Ijaz MU, et al
    Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    PLoS One. 2023;18:e0286349.
    >> Share

  73. BESSER LM, Chrisphonte S, Kleiman MJ, O'Shea D, et al
    The Healthy Brain Initiative (HBI): A prospective cohort study protocol.
    PLoS One. 2023;18:e0293634.
    >> Share

  74. LI F, Chen H, Mao N, Liu H, et al
    Dietary fiber intake and cognitive impairment in older patients with chronic kidney disease in the United States: A cross-sectional study.
    PLoS One. 2023;18:e0291690.
    >> Share

  75. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    >> Share

  76. PURRO SA, Farmer M, Noble E, Sarell CJ, et al
    Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Abeta oligomer profiles unaltered by ablation of cellular prion protein.
    PLoS One. 2023;18:e0294465.
    >> Share

  77. JAHAN S, Abu Taher K, Kaiser MS, Mahmud M, et al
    Explainable AI-based Alzheimer's prediction and management using multimodal data.
    PLoS One. 2023;18:e0294253.
    >> Share

  78. ZOU T, Zhou X, Wang Q, Zhao Y, et al
    Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    PLoS One. 2023;18:e0295320.
    >> Share

  79. WU X, Cao S, Zou Y, Wu F, et al
    Traditional Chinese Medicine studies for Alzheimer's disease via network pharmacology based on entropy and random walk.
    PLoS One. 2023;18:e0294772.
    >> Share

  80. ZANG L, Liu X, Li Y, Liu J, et al
    The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer's disease: A meta-analysis.
    PLoS One. 2023;18:e0293977.
    >> Share


  81. Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases.
    PLoS One. 2023;18:e0295638.
    >> Share

  82. TANKSLEY PT, Logan MW, Barnes JC
    History of incarceration and age-related neurodegeneration: Testing models of genetic and environmental risks in a longitudinal panel study of older adults.
    PLoS One. 2023;18:e0288303.
    >> Share

  83. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    >> Share

  84. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    >> Share

    January 2022
  85. KIM HJ, Ryou JH, Choi KT, Kim SM, et al
    Deficits in color detection in patients with Alzheimer disease.
    PLoS One. 2022;17:e0262226.
    >> Share

  86. SHABBIR U, Tyagi A, Ham HJ, Oh DH, et al
    Comprehensive profiling of bioactive compounds in germinated black soybeans via UHPLC-ESI-QTOF-MS/MS and their anti-Alzheimer's activity.
    PLoS One. 2022;17:e0263274.
    >> Share

  87. LEACH JM, Edwards LJ, Kana R, Visscher K, et al
    The spike-and-slab elastic net as a classification tool in Alzheimer's disease.
    PLoS One. 2022;17:e0262367.
    >> Share

  88. JUNG NY, Kim HS, Kim ES, Jeon S, et al
    Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.
    PLoS One. 2022;17:e0261007.
    >> Share

  89. HUANG YC, Hsu SM, Shie FS, Shiao YJ, et al
    Reduced mitochondria membrane potential and lysosomal acidification are associated with decreased oligomeric Abeta degradation induced by hyperglycemia: A study of mixed glia cultures.
    PLoS One. 2022;17:e0260966.
    >> Share

  90. QUERFURTH H, Marshall J, Parang K, Rioult-Pedotti MS, et al
    A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.
    PLoS One. 2022;17:e0261696.
    >> Share

  91. LEE JI, Lim JS, Hong JH, Kim S, et al
    Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
    PLoS One. 2022;17:e0262224.
    >> Share

  92. SADLEIR KR, Popovic J, Khatri A, Vassar R, et al
    Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis.
    PLoS One. 2022;17:e0263332.
    >> Share

  93. REHMAN S, Ali Ashfaq U, Sufyan M, Shahid I, et al
    The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2022;17:e0264074.
    >> Share

  94. SUZUKI Y, Suzuki M, Shigenobu K, Shinosaki K, et al
    A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer's dementia.
    PLoS One. 2022;17:e0265484.
    >> Share

  95. ZHANG Q, Yang X, Sun Z
    Classification of Alzheimer's disease progression based on sMRI using gray matter volume and lateralization index.
    PLoS One. 2022;17:e0262722.
    >> Share

  96. MARTIZ RM, Patil SM, Ramu R, M K J, et al
    Discovery of novel benzophenone integrated derivatives as anti-Alzheimer's agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach.
    PLoS One. 2022;17:e0265022.
    >> Share

  97. PAYNE M, Manera V, Robert P, Vandersteen C, et al
    Olfactory identification disorders due to Alzheimer's disease: A new test from France to Quebec.
    PLoS One. 2022;17:e0265764.
    >> Share

  98. IOHAN LDCC, Lambert JC, Costa MR
    Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.
    PLoS One. 2022;17:e0266405.
    >> Share

  99. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    >> Share

  100. MOUSA D, Zayed N, Yassine IA
    Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.
    PLoS One. 2022;17:e0264710.
    >> Share

  101. KORTHAUER LE, Giugliano RP, Guo J, Sabatine MS, et al
    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.
    PLoS One. 2022;17:e0266615.
    >> Share

  102. YOUSEFZADEH-NOWSHAHR E, Winter G, Bohn P, Kneer K, et al
    Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.
    PLoS One. 2022;17:e0266906.
    >> Share

  103. UCHIYAMA S, Kamoi F, Tanaka M, Joko I, et al
    What is the subtype of dementia in patients with fragility hip fracture?
    PLoS One. 2022;17:e0265636.
    >> Share

  104. ABD EL-RAHMAN SS, Fayed HM
    Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFkappaBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats.
    PLoS One. 2022;17:e0265961.
    >> Share

  105. SOLIMAN MG, Davies HA, Sharkey J, Levy R, et al
    Development of amyloid beta gold nanorod aggregates as optoacoustic probes.
    PLoS One. 2022;17:e0259608.
    >> Share

  106. BANACK SA, Stark AC, Cox PA
    A possible blood plasma biomarker for early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0267407.
    >> Share

  107. NAITO N, Hirosawa T, Tsubomoto M, Miyagishi Y, et al
    Prominent gamma band activity during visual motion perception in early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0266693.
    >> Share

  108. SOUDY R, Kimura R, Fu W, Patel A, et al
    Extracellular vesicles enriched with amylin receptor are cytoprotective against the Ass toxicity in vitro.
    PLoS One. 2022;17:e0267164.
    >> Share

  109. HERNANDEZ M, Ramon-Julvez U, Ferraz F
    Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer's disease diagnosis.
    PLoS One. 2022;17:e0264695.
    >> Share

  110. PHAM H, Yin T, D'Adamio L
    Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Abeta-coding region of App.
    PLoS One. 2022;17:e0263546.
    >> Share

  111. ANDRADE JM, Pachar P, Trujillo L, Cartuche L, et al
    Suillin: A mixed-type acetylcholinesterase inhibitor from Suillus luteus which is used by Saraguros indigenous, southern Ecuador.
    PLoS One. 2022;17:e0268292.
    >> Share

  112. CANNAVO C, Cleverley K, Maduro C, Mumford P, et al
    Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.
    PLoS One. 2022;17:e0262558.
    >> Share

  113. ALI M, Sung YJ, Wang F, Fernandez MV, et al
    Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
    PLoS One. 2022;17:e0267298.
    >> Share

  114. GARCIA MARIN ID, Camarillo Lopez RH, Martinez OA, Padilla-Martinez II, et al
    New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Abeta aggregation, AChE, and BACE1 in the Alzheimer disease.
    PLoS One. 2022;17:e0269129.
    >> Share

  115. SELF W, Awwad K, Savaryn JP, Schulz M, et al
    An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
    PLoS One. 2022;17:e0269157.
    >> Share

  116. ZAMANI J, Sadr A, Javadi AH
    Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2022;17:e0267608.
    >> Share

  117. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    >> Share

  118. FLO BK, Matziorinis AM, Skouras S, Sudmann TT, et al
    Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease.
    PLoS One. 2022;17:e0270682.
    >> Share

  119. ALI SK, Ali RH
    Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    PLoS One. 2022;17:e0271138.
    >> Share

  120. CUADRADO F, Antoli A, Fernandez-Calvo B
    The effect of framing on attitudes towards Alzheimer's disease. A comparative study between younger and older adults.
    PLoS One. 2022;17:e0270959.
    >> Share

  121. KANNAPPAN B, Gunasekaran TI, Te Nijenhuis J, Gopal M, et al
    Polygenic score for Alzheimer's disease identifies differential atrophy in hippocampal subfield volumes.
    PLoS One. 2022;17:e0270795.
    >> Share

  122. VIDONI ED, Morris JK, Palmer JA, Li Y, et al
    Dementia risk and dynamic response to exercise: A non-randomized clinical trial.
    PLoS One. 2022;17:e0265860.
    >> Share

  123. KHASAWNEH RR, Abu-El-Rub E, Alzu'bi A, Abdelhady GT, et al
    Corpus callosum anatomical changes in Alzheimer patients and the effect of acetylcholinesterase inhibitors on corpus callosum morphometry.
    PLoS One. 2022;17:e0269082.
    >> Share

  124. BAJIC VP, Salhi A, Lakota K, Radovanovic A, et al
    DES-Amyloidoses "Amyloidoses through the looking-glass": A knowledgebase developed for exploring and linking information related to human amyloid-related diseases.
    PLoS One. 2022;17:e0271737.
    >> Share

  125. BRAIN J, Tully PJ, Turnbull D, Tang E, et al
    Risk factors for dementia in the context of cardiovascular disease: A protocol of an overview of reviews.
    PLoS One. 2022;17:e0271611.
    >> Share

  126. TEJADA MORENO JA, Villegas Lanau A, Madrigal Zapata L, Baena Pineda AY, et al
    Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family.
    PLoS One. 2022;17:e0269955.
    >> Share

  127. SINCLAIR P, Kabbani N
    Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells.
    PLoS One. 2022;17:e0270479.
    >> Share

  128. FAVERO F, Barberis E, Gagliardi M, Espinoza S, et al
    A Metabologenomic approach reveals alterations in the gut microbiota of a mouse model of Alzheimer's disease.
    PLoS One. 2022;17:e0273036.
    >> Share

  129. ACQUARELLI J, van Laarhoven T, Postma GJ, Jansen JJ, et al
    Convolutional neural networks to predict brain tumor grades and Alzheimer's disease with MR spectroscopic imaging data.
    PLoS One. 2022;17:e0268881.
    >> Share

  130. NAMCHAIW P, Bunreangsri P, Eiamcharoen P, Eiamboonsert S, et al
    An in vitro workflow of neuron-laden agarose-laminin hydrogel for studying small molecule-induced amyloidogenic condition.
    PLoS One. 2022;17:e0273458.
    >> Share

  131. FANG Y, Doyle MF, Chen J, Alosco ML, et al
    Association between inflammatory biomarkers and cognitive aging.
    PLoS One. 2022;17:e0274350.
    >> Share

  132. HLYNIALUK C, Kemper L, Leinonen-Wright K, Petersen RC, et al
    Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer's disease, Huntington's disease, or Lewy Body dementia.
    PLoS One. 2022;17:e0274784.
    >> Share

  133. WEI Y, Heun-Johnson H, Tysinger B
    Using dynamic microsimulation to project cognitive function in the elderly population.
    PLoS One. 2022;17:e0274417.
    >> Share

  134. HOHBERGER B, Pruss H, Mardin C, Lammer R, et al
    Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
    PLoS One. 2022;17:e0272811.
    >> Share

  135. SUGIOKA J, Suzumura S, Kuno K, Kizuka S, et al
    Relationship between finger movement characteristics and brain voxel-based morphometry.
    PLoS One. 2022;17:e0269351.
    >> Share

  136. WONG J, Steyn JS, Pienaar IS, Elson JL, et al
    Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations.
    PLoS One. 2022;17:e0276169.
    >> Share

  137. SU S, Esparza TJ, Brody DL
    Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
    PLoS One. 2022;17:e0276107.
    >> Share

  138. KANNAPPAN B, Te Nijenhuis J, Choi YY, Lee JJ, et al
    Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
    PLoS One. 2022;17:e0275233.
    >> Share

  139. NASIRI M, Moayedfar S, Purmohammad M, Ghasisin L, et al
    Investigating sentence processing and working memory in patients with mild Alzheimer and elderly people.
    PLoS One. 2022;17:e0266552.
    >> Share

  140. ZARETSKY DV, Zaretskaia MV, Molkov YI
    Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.
    PLoS One. 2022;17:e0276933.
    >> Share

  141. RANTS'O TA, van Greunen DG, van der Westhuizen CJ, Riley DL, et al
    The in silico and in vitro analysis of donepezil derivatives for Anopheles acetylcholinesterase inhibition.
    PLoS One. 2022;17:e0277363.
    >> Share

  142. TOLEDO JB, Rashid T, Liu H, Launer L, et al
    SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline.
    PLoS One. 2022;17:e0276392.
    >> Share

  143. KARAMAN BK, Mormino EC, Sabuncu MR
    Machine learning based multi-modal prediction of future decline toward Alzheimer's disease: An empirical study.
    PLoS One. 2022;17:e0277322.
    >> Share

  144. BARTELS SL, Shaaban CE, Brum WS, Welikovitch LA, et al
    Impact of the COVID-19 pandemic on early career dementia researchers: A global online survey.
    PLoS One. 2022;17:e0277470.
    >> Share

  145. CHAN D, Suk HJ, Jackson BL, Milman NP, et al
    Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies.
    PLoS One. 2022;17:e0278412.
    >> Share

  146. JUNG JH, Kim G, Byun MS, Lee JH, et al
    Gut microbiome alterations in preclinical Alzheimer's disease.
    PLoS One. 2022;17:e0278276.
    >> Share

  147. XIA W, Gao Z, Jiang X, Jiang L, et al
    Alzheimer's risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/beta-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer.
    PLoS One. 2022;17:e0278774.
    >> Share

  148. MAFI JN, Walling AM, Villaflores C, Vangala S, et al
    A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias.
    PLoS One. 2022;17:e0277409.
    >> Share

  149. OIZUMI H, Sugimura Y, Totsune T, Kawasaki I, et al
    Plasma sphingolipid abnormalities in neurodegenerative diseases.
    PLoS One. 2022;17:e0279315.
    >> Share

  150. MCCARTHY MM, Hardy MJ, Leising SE, LaFollette AM, et al
    An amino-terminal fragment of apolipoprotein E4 leads to behavioral deficits, increased PHF-1 immunoreactivity, and mortality in zebrafish.
    PLoS One. 2022;17:e0271707.
    >> Share

  151. CARDOEN B, Wong T, Alan P, Lee S, et al
    SPECHT: Self-tuning Plausibility based object detection Enables quantification of Conflict in Heterogeneous multi-scale microscopy.
    PLoS One. 2022;17:e0276726.
    >> Share

    January 2021
  152. PENNER G, Lecocq S, Chopin A, Vedoya X, et al
    Aptamarker prediction of brain amyloid-beta status in cognitively normal individuals at risk for Alzheimer's disease.
    PLoS One. 2021;16:e0243902.
    >> Share

  153. VIDONI ED, Morris JK, Watts A, Perry M, et al
    Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial.
    PLoS One. 2021;16:e0244893.
    >> Share

  154. MEGHDADI AH, Stevanovic Karic M, McConnell M, Rupp G, et al
    Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    PLoS One. 2021;16:e0244180.
    >> Share

  155. TOKUMITSU K, Yasui-Furukori N, Takeuchi J, Yachimori K, et al
    The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    PLoS One. 2021;16:e0247427.
    >> Share

  156. CHELLAPPA RC, Lukose B, Rani P
    Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2021;16:e0248252.
    >> Share

  157. VOIGT RM, Raeisi S, Yang J, Leurgans S, et al
    Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
    PLoS One. 2021;16:e0240342.
    >> Share

  158. GJERUM L, Andersen BB, Bruun M, Simonsen AH, et al
    Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.
    PLoS One. 2021;16:e0248413.
    >> Share

  159. ZABEL P, Kaluzny JJ, Zabel K, Kaluzna M, et al
    Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma.
    PLoS One. 2021;16:e0248284.
    >> Share

  160. BAHADO-SINGH RO, Vishweswaraiah S, Aydas B, Yilmaz A, et al
    Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
    PLoS One. 2021;16:e0248375.
    >> Share

  161. KIM D, Lee JH, Kim HY, Shin J, et al
    Correction: Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2021;16:e0250194.
    >> Share

  162. TSUNEISHI M, Yamamoto T, Yamaguchi T, Kodama T, et al
    Association between number of teeth and Alzheimer's disease using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2021;16:e0251056.
    >> Share

  163. VELAZQUEZ M, Lee Y
    Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
    PLoS One. 2021;16:e0244773.
    >> Share

  164. MCCORMICK JW, Ammerman L, Chen G, Vogel PD, et al
    Transport of Alzheimer's associated amyloid-beta catalyzed by P-glycoprotein.
    PLoS One. 2021;16:e0250371.
    >> Share

  165. WEN LY, Wan L, Lai JN, Chen CS, et al
    Increased risk of Alzheimer's disease among patients with age-related macular degeneration: A nationwide population-based study.
    PLoS One. 2021;16:e0250440.
    >> Share

  166. STOJANOVIC F, Taktek M, Khieu NH, Huang J, et al
    NMR analysis of the correlation of metabolic changes in blood and cerebrospinal fluid in Alzheimer model male and female mice.
    PLoS One. 2021;16:e0250568.
    >> Share

  167. ZHENG C, Xu R
    Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization.
    PLoS One. 2021;16:e0250278.
    >> Share

  168. JIANG X, Howard JH Jr, Rebeck GW, Turner RS, et al
    Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
    PLoS One. 2021;16:e0252958.
    >> Share

  169. ZHANG J, Zhang Y, Zou J, Cao F, et al
    A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease.
    PLoS One. 2021;16:e0253206.
    >> Share

  170. FUKUI K, Kimura S, Kato Y, Kohno M, et al
    Effects of far infrared light on Alzheimer's disease-transgenic mice.
    PLoS One. 2021;16:e0253320.
    >> Share

  171. WENG J, Zhao G, Weng L, Guan J, et al
    Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
    PLoS One. 2021;16:e0252969.
    >> Share

  172. MINICUCCI J, Alfond M, Demuro A, Gerberry D, et al
    Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
    PLoS One. 2021;16:e0246116.
    >> Share

  173. TOPPING M, Kim J, Fletcher J
    Geographic variation in Alzheimer's disease mortality.
    PLoS One. 2021;16:e0254174.
    >> Share

  174. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    >> Share

  175. LIBOWITZ MR, Wei K, Tran T, Chu K, et al
    Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.
    PLoS One. 2021;16:e0254332.
    >> Share

  176. HUI J, Zhao Y, Yu S, Liu J, et al
    Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
    PLoS One. 2021;16:e0255362.
    >> Share

  177. LEE SH, Chen YH, Chien CC, Yan YH, et al
    Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    PLoS One. 2021;16:e0254587.
    >> Share

  178. SAKUTA S, Hashimoto M, Ikeda M, Koyama A, et al
    Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?
    PLoS One. 2021;16:e0247184.
    >> Share

  179. PIERSSON AD, Ibrahim B, Suppiah S, Mohamad M, et al
    Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
    PLoS One. 2021;16:e0252883.
    >> Share

  180. WICKLAND DP, Ren Y, Sinnwell JP, Reddy JS, et al
    Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies.
    PLoS One. 2021;16:e0249305.
    >> Share

  181. VESPA A, Spatuzzi R, Fabbietti P, Penna M, et al
    Association between care burden, depression and personality traits in Alzheimer's caregiver: A pilot study.
    PLoS One. 2021;16:e0251813.
    >> Share

  182. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    >> Share

  183. KOLINGER GD, Vallez Garcia D, Willemsen ATM, Reesink FE, et al
    Amyloid burden quantification depends on PET and MR image processing methodology.
    PLoS One. 2021;16:e0248122.
    >> Share

  184. FERNANDEZ-BLAZQUEZ MA, Del Ser T, Frades-Payo B, Avila-Villanueva M, et al
    MADRID+90 study on factors associated with longevity: Study design and preliminary data.
    PLoS One. 2021;16:e0251796.
    >> Share

  185. CALDERON C, Beyle C, Veliz-Garcia O, Bekios-Calfa J, et al
    Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.
    PLoS One. 2021;16:e0251137.
    >> Share

  186. AKBOR MM, Kurosawa N, Nakayama H, Nakatani A, et al
    Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta.
    PLoS One. 2021;16:e0248027.
    >> Share

  187. PARWEEN F, Hossain MS, Singh KP, Gupta RD, et al
    Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.
    PLoS One. 2021;16:e0258879.
    >> Share

  188. NOGUCHI-SHINOHARA M, Koike M, Morise H, Kudo K, et al
    MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2021;16:e0259677.
    >> Share

  189. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    >> Share

  190. WU Y, Whittaker HT, Noy S, Cleverley K, et al
    The effects of Cstb duplication on APP/amyloid-beta pathology and cathepsin B activity in a mouse model.
    PLoS One. 2021;16:e0242236.
    >> Share

  191. JIANG H, Esparza TJ, Kummer TT, Brody DL, et al
    Unbiased high-content screening reveals Abeta- and tau-independent synaptotoxic activities in human brain homogenates from Alzheimer's patients and high-pathology controls.
    PLoS One. 2021;16:e0259335.
    >> Share

  192. JIANG J, Liu H, Wang Z, Tian H, et al
    Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model.
    PLoS One. 2021;16:e0259530.
    >> Share

  193. CZAPSKI GA, Cieslik M, Bialopiotrowicz E, Lukiw WJ, et al
    Down-regulation of cyclin D2 in amyloid beta toxicity, inflammation, and Alzheimer's disease.
    PLoS One. 2021;16:e0259740.
    >> Share

  194. GRUNDMAN J, Spencer B, Sarsoza F, Rissman RA, et al
    Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression.
    PLoS One. 2021;16:e0251611.
    >> Share

  195. WU X, Peng C, Nelson PT, Cheng Q, et al
    Random forest-integrated analysis in AD and LATE brain transcriptome-wide data to identify disease-specific gene expression.
    PLoS One. 2021;16:e0256648.
    >> Share

  196. SHIMODA A, Li Y, Hayashi H, Kondo N, et al
    Dementia risks identified by vocal features via telephone conversations: A novel machine learning prediction model.
    PLoS One. 2021;16:e0253988.
    >> Share

  197. XIN XY, Lai ZH, Ding KQ, Zeng LL, et al
    Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
    PLoS One. 2021;16:e0260498.
    >> Share

  198. HIRALDO-GONZALEZ L, Trillo-Contreras JL, Garcia-Miranda P, Pineda-Sanchez R, et al
    Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.
    PLoS One. 2021;16:e0258165.
    >> Share

  199. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
    Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
    PLoS One. 2021;16:e0253216.
    >> Share

  200. SCHOBER J, Polina J, Walters F, Scott N, et al
    NNC 26-9100 increases Abeta1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells.
    PLoS One. 2021;16:e0254242.
    >> Share

  201. KAMAL S, Park I, Kim YJ, Kim YJ, et al
    Alteration of the corpus callosum in patients with Alzheimer's disease: Deep learning-based assessment.
    PLoS One. 2021;16:e0259051.
    >> Share

  202. ZUELKE AE, Riedel-Heller SG, Wittmann F, Pabst A, et al
    Gender-specific design and effectiveness of non-pharmacological interventions against cognitive decline and dementia-protocol for a systematic review and meta-analysis.
    PLoS One. 2021;16:e0256826.
    >> Share

  203. KAYA-TILKI E, Dikmen M
    Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.
    PLoS One. 2021;16:e0260633.
    >> Share

    January 2020
  204. BOUBAKRI A, Leri M, Bucciantini M, Najjaa H, et al
    Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease.
    PLoS One. 2020;15:e0223815.
    >> Share

  205. MITSUMORI R, Sakaguchi K, Shigemizu D, Mori T, et al
    Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.
    PLoS One. 2020;15:e0239196.
    >> Share

  206. RONCERO C, Nikelski J, Probst S, Fernandez A, et al
    The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative disease.
    PLoS One. 2020;15:e0235810.
    >> Share

  207. GUPTA A, Kennedy K, Perales-Puchalt J, Drew D, et al
    Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
    PLoS One. 2020;15:e0239871.
    >> Share

  208. GAO Y, Sengupta A, Li M, Zu Z, et al
    Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    PLoS One. 2020;15:e0240513.
    >> Share

  209. C RC, Lukose B, Rani P
    G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2020;15:e0225487.
    >> Share

  210. KUEPER JK, Lizotte DJ, Montero-Odasso M, Speechley M, et al
    Cognition and motor function: The gait and cognition pooled index.
    PLoS One. 2020;15:e0238690.
    >> Share

  211. YAO T, Sweeney E, Nagorski J, Shulman JM, et al
    Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
    PLoS One. 2020;15:e0241707.
    >> Share

  212. YOKOSAWA K, Kimura K, Takase R, Murakami Y, et al
    Functional decline of the precuneus associated with mild cognitive impairment: Magnetoencephalographic observations.
    PLoS One. 2020;15:e0239577.
    >> Share

  213. AHMED S, Kim BC, Lee KH, Jung HY, et al
    Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging.
    PLoS One. 2020;15:e0242712.
    >> Share

  214. SEDGHIZADEH MJ, Hojjati H, Ezzatdoost K, Aghajan H, et al
    Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    PLoS One. 2020;15:e0243535.
    >> Share

  215. OKUDA M, Fujita Y, Takada-Takatori Y, Sugimoto H, et al
    Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.
    PLoS One. 2020;15:e0240378.
    >> Share

  216. GUYON A, Rousseau J, Lamothe G, Tremblay JP, et al
    The protective mutation A673T in amyloid precursor protein gene decreases Abeta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
    PLoS One. 2020;15:e0237122.
    >> Share

  217. KIM D, Lee JH, Kim HY, Shin J, et al
    Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2020;15:e0243041.
    >> Share

  218. DENG Y, Wu S, Fan H
    Genome-wide pathway-based quantitative multiple phenotypes analysis.
    PLoS One. 2020;15:e0240910.
    >> Share

  219. LI QS, Tian C, Hinds D, Seabrook GR, et al
    The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.
    PLoS One. 2020;15:e0241552.
    >> Share

  220. MENTINK LJ, Thomas J, Melis RJF, Olde Rikkert MGM, et al
    Home-EEG assessment of possible compensatory mechanisms for sleep disruption in highly irregular shift workers - The ANCHOR study.
    PLoS One. 2020;15:e0237622.
    >> Share

  221. GREEN EH, Kikis EA
    Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans.
    PLoS One. 2020;15:e0243419.
    >> Share

  222. BORGSTEDT L, Blobner M, Musiol M, Bratke S, et al
    Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia.
    PLoS One. 2020;15:e0242989.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016